It had been one of a lot more than 450 entries in the association publications contest.

We are proud of our new Biologic Chemotherapeutic Therapy for the Non-Cancer Pediatric Patients flash get, but are a lot more proud of our talented volunteer leaders and staff that have developed this and several other products. It is a satisfaction and an honor to serve the field of pediatric hematology/oncology nursing. Dave Bergeson, APHON Executive Director. Related StoriesMD Anderson research reveals why chemotherapy medicines not effective for most pancreatic cancer patientsStudy displays rare HER2 missense mutations do not spread breasts cancer on their ownCornell biomedical engineers develop 'super organic killer cells' to destroy tumor cells in lymph nodesAPHON is the professional organization for pediatric hematology/oncology nurses and various other pediatric hematology/oncology health care professionals.AIDS patients in poor areas to get medication access HIV/AIDS individuals in poor countries may finally access the antiretroviral medications they desperately need. Drugmaker Gilead Sciences Inc. Tuesday its intend to allow four of its Helps drugs to be produced by generic manufacturers announced, raising their availability in poor countries – particularly in Africa potentially. Most of the 33 million people worldwide who’ve HIV go on the continent. In the first offer of its kind, the pharmaceutical organization agreed to provide the medications in return for three to five % of royalties, US health officials said.